- Credit Suisse 25 th Annual Healthcare Conference on November 7 in Scottsdale, Arizona - Jefferies 2016 London Healthcare Conference on November 16 in London - Citi 2016 Global Healthcare Conference on December 8 in New York City SAN RAFAEL, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Credit Suisse 25 th Annual Healthcare Conference on November 7, 2016 at 10:00am MT/12:00pm ET, in Scottsdale, Arizona. Management will also participate in the Jefferies 2016 London Healthcare Conference on November 16, 2016, in London and the Citi 2016 Global Healthcare Conference on December 8, 2016 at 8:45am ET, in New York City. Webcasts will be available for the Credit Suisse and Citi conferences. To access the live webcasts, please visit the investor section of the BioMarin website, www.BMRN.com. A replay will also be archived on the site for at least one week following the event. About BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts:InvestorsTraci McCartyBioMarin Pharmaceutical Inc.(415) 455-7558MediaDebra CharlesworthBioMarin Pharmaceutical Inc.(415) 455-7451